Class II · Moderate risk
babyganics
Failed stability specifications: during routine stability monitoring quality concerns were identified. Physical separation for ingredients was observed.
FDA drug recalls in 2025
Every FDA drug recall initiated in 2025, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
778 recalls, newest first.
Class III · Low risk
Guaifenesin and Codeine Phosphate Oral Solution USP
Superpotent; sodium benzoate preservative
Class II · Moderate risk
Clobazam Tablets
Presence of Foreign Tablets/Capsules